Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

Grossbard, M L; Lambert, J M; Goldmacher, V S; Spector, N L; Kinsella, J; Eliseo, L; Coral, F; Taylor, J A; Blättler, W A; Epstein, C L

Grossbard, M L; Lambert, J M; Goldmacher, V S; Spector, N L; Kinsella, J; Eliseo, L; Coral, F; Taylor, J A; Blättler, W A; Epstein, C L.

Affiliation

Grossbard ML; Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.

J Clin Oncol ; 11(4): 726-37, 1993 Apr.

Article in En | MEDLINE | ID: mdl-7683045

Subject(s)

Antibodies, Monoclonal; Immunotoxins/therapeutic use; Leukemia, Lymphocytic, Chronic, B-Cell/therapy; Lymphoma, B-Cell/therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy; Ricin; Adult; Aged; Animals; Antibodies, Monoclonal/immunology; Antibody Formation; Antigens, CD/immunology; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte/immunology; Cells, Cultured; Cytotoxicity, Immunologic; Female; Humans; Immunotoxins/adverse effects; Immunotoxins/immunology; Macaca mulatta; Male; Middle Aged; Ricin/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Ricin / Leukemia, Lymphocytic, Chronic, B-Cell / Immunotoxins / Lymphoma, B-Cell / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antibodies, Monoclonal Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links